We are live on
!
Find out more
EFM
E Fund Management Portfolio holdings
AUM
$3.37B
This Fund
S&P 500
This Quarter
Est. Return
-1.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
-$105M
(-7.7%)
Cap. Flow
-$52.6M
Cap. Flow
% of AUM
-4.16%
Top 10 Holdings %
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$51.8M |
| 2 |
KE Holdings
BEKE
|
+$31M |
| 3 |
TSMC
TSM
|
+$10.9M |
| 4 |
Kanzhun
BZ
|
+$6.35M |
| 5 |
iQIYI
IQ
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tencent Music
TME
|
+$39.2M |
| 2 |
Trip.com Group
TCOM
|
+$19.3M |
| 3 |
Marvell Technology
MRVL
|
+$12M |
| 4 |
Weibo
WB
|
+$7.99M |
| 5 |
JOYY
JOYY Inc
JOYY
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.28% |
| 2 | Technology | 32.43% |
| 3 | Communication Services | 9.6% |
| 4 | Healthcare | 8.37% |
| 5 | Real Estate | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CoStar Group
CSGP
$11.3B
| $340K | 0.03% |
3,823
-558
| -13% | -$43.1K |
|
|
SWTX
202
DELISTED
SpringWorks Therapeutics
SWTX
| $340K | 0.03% |
12,950
+528
| +4% | +$13.9K |
|
203
Krystal Biotech
KRYS
$9.88B
| $335K | 0.03% |
2,857
-631
| -18% | -$64.4K |
|
204
Veracyte
VCYT
$4.52B
| $333K | 0.03% |
13,085
-3,422
| -21% | -$83K |
|
205
Bank of America
BAC
$435B
| $332K | 0.03% |
11,579
-1,422
| -11% | -$40.6K |
|
206
Electronic Arts
EA
$52.4B
| $329K | 0.03% |
2,540
-389
| -13% | -$49.3K |
|
207
Arcus Biosciences
RCUS
$3.57B
| $328K | 0.03% |
16,136
-7,199
| -31% | -$137K |
|
|
RNAM
208
DELISTED
Avidity Biosciences
RNAM
| $327K | 0.03% |
29,464
+11,943
| +68% | +$150K |
|
209
Xcel Energy
XEL
$51B
| $321K | 0.03% |
5,162
-755
| -13% | -$50.4K |
|
210
Bristol-Myers Squibb
BMY
$127B
| $317K | 0.03% |
4,953
-471
| -9% | -$31.6K |
|
211
AstraZeneca
AZN
$263B
| $316K | 0.03% |
2,210
-475
| -18% | -$69.9K |
|
212
Fastenal
FAST
$54B
| $316K | 0.03% |
10,720
-1,578
| -13% | -$43.2K |
|
213
Linde
LIN
$237B
| $312K | 0.02% |
818
-100
| -11% | -$36.5K |
|
214
Viridian Therapeutics
VRDN
$2.13B
| $312K | 0.02% |
13,122
+3,078
| +31% | +$79K |
|
215
Verisk Analytics
VRSK
$26.4B
| $306K | 0.02% |
1,355
-315
| -19% | -$66.2K |
|
|
CERE
216
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $302K | 0.02% |
9,501
-2,431
| -20% | -$74.6K |
|
217
Baker Hughes
BKR
$56.8B
| $299K | 0.02% |
9,471
-1,409
| -13% | -$41.1K |
|
218
Viking Therapeutics
VKTX
$4.04B
| $298K | 0.02% |
18,403
-12,273
| -40% | -$257K |
|
|
DVAX
219
DELISTED
Dynavax Technologies
DVAX
| $297K | 0.02% |
22,959
-7,758
| -25% | -$88.4K |
|
220
Dollar Tree
DLTR
$23.1B
| $294K | 0.02% |
2,048
-310
| -13% | -$45.6K |
|
221
Medtronic
MDT
$107B
| $294K | 0.02% |
3,340
-395
| -11% | -$34K |
|
222
Keysight
KEYS
$54.5B
| $293K | 0.02% |
1,747
-179
| -9% | -$27.8K |
|
|
BLUE
223
DELISTED
bluebird bio
BLUE
| $291K | 0.02% |
4,430
-177
| -4% | -$12.9K |
|
224
Warner Bros
WBD
$64.6B
| $282K | 0.02% |
22,493
-3,266
| -13% | -$42.4K |
|
225
Constellation Energy
CEG
$98B
| $279K | 0.02% |
3,046
-478
| -14% | -$39.6K |
|
Similar funds
VFCM
DFO
DIA
5NCM
TAM
CS
OAM
QCG
E Fund Management's Q2 2023 Portfolio in Review
As of Q2 2023, E Fund Management held 343 positions worth $1.26B, down 7.7% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
E Fund Management withdrew a net $52.6M in Q2 2023, closing 34 positions and reducing 233 holdings. Its most notable exit was Trip.com Group, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 36% a quarter earlier, followed by Technology and Communication Services.
Against the trend, E Fund Management opened a new position in Datadog worth $881K.
- E Fund Management's largest Q2 2023 buy was Datadog: 8,960 shares worth $881K.
- E Fund Management added most to Pinduoduo in Q2 2023, an estimated $51.8M increase.
- E Fund Management's biggest Q2 2023 reduction was Tencent Music, cutting an estimated $39.2M.
- E Fund Management fully exited Trip.com Group in Q2 2023, selling an estimated $19.3M.
- E Fund Management's ten largest holdings make up 61% of its $1.26B portfolio in Q2 2023.
- E Fund Management opened 11 new positions and closed 34 in Q2 2023.
- E Fund Management's portfolio value fell 7.7% quarter-over-quarter to $1.26B.
Based on E Fund Management's 13F filing for Q2 2023, filed 11 Aug 2023.